欧美日韩精品无码专区,成年无码av片,成品漫画免登录去广告版,亚洲精品一区国产

Genocea Biosciences,  
致力于利用T細胞免疫發(fā)展新一代疫苗

Genocea is harnessing the power of T cell immunity to develop the next generation of vaccines. T cells are increasingly recognized as a critical element of protective immune responses to a wide range of infectious disease pathogens, but are difficult to target using traditional vaccine discovery methods. Genocea is able to identify protective T cell antigens in humans exposed to a pathogen using ATLAS?, its proprietary technology platform, potentially enabling vaccines against pathogens for which vaccine solutions do not exist or are sub-optimal. Genocea’s pipeline of novel T cell vaccines includes GEN-003 for HSV-2 therapy, GEN-004, and earlier-stage programs in chlamydia, HSV-2 prophylaxis and malaria.